Beijing Baipusi Biotechnology Co., Ltd. (hereinafter referred to as "the Company") announces the implementation of the 2025 annual equity distribution plan, which was approved at the 2025 annual shareholders' meeting held on May 12, 2026. The details of the equity distribution are as follows:
1. Approval of Profit Distribution Plan
- The shareholders' meeting approved the profit distribution plan for 2025, agreeing to distribute a cash dividend of RMB 6.00 (tax included) for every 10 shares based on the total share capital of 167,177,695 shares, amounting to a total cash dividend of RMB 100,306,617. No stock dividends will be issued, nor will there be any capital reserve transfers to increase share capital. The remaining undistributed profits will be carried forward to future distributions. If there are changes in the share capital before the equity distribution record date, the total cash dividend will be adjusted accordingly while maintaining the distribution ratio per share.
- There have been no changes in the total share capital from the disclosure of the distribution plan to the implementation period.
- The distribution plan implemented is consistent with the plan approved by the shareholders' meeting and its adjustment principles.
- The implementation of the equity distribution is within two months of the shareholders' meeting approval.